Literature DB >> 14722005

Ultrafast computed tomography for quality control of automated proximal anastomoses.

Sven Martens1, Christopher Herzog, Markus Dietrich, Mirko Doss, Gerhard Wimmer-Greinecker, Anton Moritz.   

Abstract

BACKGROUND: The Symmetry aortic connector uses a nitinol implant to create proximal anastomoses with saphenous vein grafts. Multiple detector-row cardiac computed tomography (MDCT) is used as a noninvasive method of quality control at our institution.
METHODS: In 50 elective coronary artery bypass grafting patients who participated in a randomized trial comparing automated with conventionally hand-sewn proximal anastomoses, MDC T was performed on postoperative day 5. Fifty-three automated Symmetry anastomoses were created in 34 patients (group 1). Twenty-five conventionally hand-sewn anastomoses created in 16 patients served as controls (group 2). Graft patency and the presence or absence of high-grade stenosis at the proximal anastomotic site were evaluated.
RESULTS: In group 1, 2 (3.8%) of the grafts were found occluded at MDCT or coronary angiography, and no further relevant stenosis was observed. In group 2, at postoperative MDCT all grafts were found patent without significant narrowing of the proximal anastomotic site.
CONCLUSIONS: The feasibility of proximal anastomoses using the Symmetry device has been reported. Patency control with invasive angiography has been performed by other groups. With MDCT, noninvasive evaluation of proximal anastomotic quality and graft patency is possible, even if nitinol is implanted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14722005

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  1 in total

1.  MDCT of the proximal anastomoses created by nitinol implants in coronary artery bypass grafting: a retrospective two-observer evaluation.

Authors:  M Fawad Khan; Christopher Herzog; Kai Landenberger; Sven Martens; Adel Maataoui; Hanns Ackermann; Markus Dietrich; Anton Moritz; Thomas J Vogl
Journal:  Eur Radiol       Date:  2004-11-24       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.